Artelo Biosciences, Inc.
ARTL
$5.98
-$0.21-3.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.64% | -38.60% | -31.07% | -36.95% | -0.62% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 385.19% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 354.43% | 320.95% | 321.27% | 98.02% | 87.74% |
| Change in Net Operating Assets | -177.95% | 12.01% | 93.38% | 1,041.81% | 544.31% |
| Cash from Operations | -131.54% | -15.83% | -2.04% | 2.42% | 41.98% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -101.31% | -100.95% | -100.80% | -97.50% | 20.93% |
| Cash from Investing | -101.31% | -100.95% | -100.80% | -97.50% | 20.93% |
| Total Debt Issued | -37.04% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,277.55% | 28,935.09% | 5,509.82% | 5,164.37% | 82.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 692.69% | 31,000.00% | 6,031.25% | 6,011.49% | 201.13% |
| Foreign Exchange rate Adjustments | -211.11% | -2,300.00% | -187.50% | -- | 20.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.92% | 2,221.83% | -264.36% | -253.49% | 124.49% |